Transparency

At Zentiva, we are deeply committed to transparency in our collaboration with doctors, patient organisations, and other healthcare sector partners.

As a UK affiliate, we report transfers of value in line with the Medicines for Europe Code of Practice, the EFPIA Disclosure Code, and the ABPI Code of Practice disclosure framework. This includes any direct, indirect, or in-kind payments made to healthcare organisations, patient associations, healthcare professionals, and research and development partnerships, which we list on this page.

Zentiva Pharma UK TOV declaration for 2022, 2023 and 2024 can be found in the attached files

    Zentiva Pharma UK Transfer of Value 2024 explanatory statement | PDF file, 205 KB
    Download
    Zentiva Pharma UK Transfer of Value Declaration 2024 | PDF file, 205 KB
    Download
    Zentiva Pharma UK Transfer of Value 2023 explanatory statement | PDF file, 204 KB
    Download
    Zentiva Pharma UK Transfer of Value Declaration 2023 | PDF file, 164 KB
    Download
    Zentiva Pharma UK Transfer of Value 2022 explanatory statement | PDF file, 187 KB
    Download
    Zentiva Pharma UK Transfer of Value Declaration 2022 | PDF file, 167 KB
    Download

Governance and policies

As part of our ongoing commitment to transparency, Zentiva ensures that all policies, codes, and guidelines governing our activities are accessible across all stakeholder groups and aligned with industry standards.

EXPLORE MORE

Date of Preparation: March 2026  |  Reference: 000820194